Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea.

Jason G PowellChris PiszczatoskiScott Garland

Published in: The Annals of pharmacotherapy (2020)

In clinical trials, solriamfetol has shown dose-dependent improvement in wakefulness over placebo and adds another option for clinicians when treating ES in narcolepsy and OSA.

Keyphrases

obstructive sleep apnea
clinical trial
positive airway pressure
phase iii
sleep apnea
double blind
palliative care
weight gain
phase ii
open label
randomized controlled trial
body mass index
placebo controlled
physical activity